NCT05983198
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05983198
Title Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT (SatisfACtion)
Acronym SatisfACtion
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | CAN | AUS

Facility Status City State Zip Country Details
BAMF Health RECRUITING Grand Rapids Michigan 49503 United States Details
Mayo Clinic Rochester RECRUITING Rochester Minnesota 55905 United States Details
Novartis Investigative Site RECRUITING Darlinghurst New South Wales 2010 Australia Details
Novartis Investigative Site RECRUITING Melbourne Victoria 3004 Australia Details
Novartis Investigative Site RECRUITING Montreal Quebec H2X 1R9 Canada Details
Novartis Investigative Site RECRUITING Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site RECRUITING Dijon Cote D Or 21034 France Details
Novartis Investigative Site RECRUITING Clermont-Ferrand 63011 France Details
Novartis Investigative Site RECRUITING Lyon 69373 France Details
Novartis Investigative Site RECRUITING Nantes 44093 France Details
Novartis Investigative Site RECRUITING Saint-Herblain 44805 France Details
Novartis Investigative Site RECRUITING Vandœuvre-lès-Nancy 54511 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field